Group 1 - The company, Chengdu Berry Genomics Technology Co., Ltd., is undergoing a judicial auction of shares held by a significant shareholder, Hou Ying, with a total of 13,785,075 shares being auctioned [1][2] - The auction took place from July 8 to July 9, 2025, on the Taobao judicial auction platform, with a total transaction value of approximately 173.45 million yuan for 13,385,075 shares [2] - The remaining 400,000 shares were not sold and will be disposed of according to subsequent rulings by the Chengdu Financial Court [2][3] Group 2 - The shares involved in the auction are all unrestricted circulating shares and have been pledged, leading to judicial freezing and marking [1] - After the acquisition of shares through the auction, the buyer must adhere to relevant laws and regulations, including a six-month trading restriction on the acquired shares [2] - The cumulative shares auctioned from Hou Ying represent 5.60% of the company's total share capital, with her remaining holdings being 0.11% [2]

成都市贝瑞和康基因技术股份有限公司 证券代码：000710 证券简称：贝瑞基因 公告编号：2025-038 关于控股股东及其一致行动人权益变动触及1%整数倍的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 控股股东高扬先生及一致行动人侯颖女士保证向本公司提供的信息内容真 实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 成都市贝瑞和康基因技术股份有限公司（以下简称"贝瑞基因"或"公 司"）于近日接到控股股东之一致行动人侯颖女士所持有股份发生变动的通 知，现将本次权益变动的具体情况公告如下： | 1．基本情况 | | | | --- | --- | --- | | 信息披露义务人 | 高扬 | | | | 侯颖（高扬之一致行动人） | | | 住所 | 北京市昌平区科技园区生命园路 | 4 号院 5 号楼 | | 权益变动时间 | 2025 年 7 月 22 | 日-2025 年 7 月 24 日 | | | | 侯颖女士因股票质押违约被成渝金融法院裁定在淘宝 网 司 法 拍 卖 网 ...

证券代码：000710 证券简称：贝瑞基因 公告编号：2025-039 成都市贝瑞和康基因技术股份有限公司 关于控股股东之一致行动人所持公司股份被司法拍卖的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次拍卖标的物为公司控股股东之一致行动人侯颖女士持有的本公司 13,785,075 股股票，占其持有公司股份的比例为 100.00%，占公司总股本的比例 为 3.90%。上述将被司法拍卖的股份均为无限售流通股，均已被质押并分别被司 法再冻结和司法标记。 2、本次司法拍卖的 13,385,075 股股份已完成过户，侯颖女士被动减持本公 司股份 13,385,075 股，其余 400,000 股股份流拍，流拍股份将依据成渝金融法 院后续裁定进行处置，公司将持续关注后续进展并根据相关法律法规的规定履行 信息披露义务。另外，竞买人通过本次司法拍卖以非交易过户方式取得本公司的 股份，需按照有关法律、行政法规、部门规章、规范性文件及深圳证券交易所的 有关规定执行，在受让后六个月内不得交易其所受让的股份。 二、本次司法拍卖的进展情况 根据成渝金融法 ...

成都市贝瑞和康基因技术股份有限公司 简式权益变动报告书 上市公司名称：成都市贝瑞和康基因技术股份有限公司 股票上市地点：深圳证券交易所 股票简称：贝瑞基因 股票代码：000710 信息披露义务人一：高扬 住所及通讯地址：北京市昌平区科技园区生命园路4号院5号楼 邮政编码：102200 信息披露义务人二：侯颖 住所及通讯地址：北京市昌平区科技园区生命园路4号院5号楼 邮政编码：102200 股份变动性质：司法强制执行和司法拍卖导致触及信息披露义务 签署日期：2025年7月25日 一、本报告书系信息披露义务人依据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司收购管理办法》《公开发行证券的公司信息披露内容与格式 准则第15号—权益变动报告书》及相关法律、法规及部门规章的有关规定编制。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反 信息披露义务人内部规则中的任何条款，或与之冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》及《公开发行证 券的公司信息披露内容与格式准则第15号——权益变动报告书》的规定，本报告书已 全面披露了信息披露义务人在成都市贝瑞和康基因技术股份 ...

Group 1 - Hualing Cable recently won multiple contracts totaling approximately 557 million yuan, accounting for 13.40% of its audited revenue for 2024 [1] - The projects include contracts from Southern Power Grid, China Institute of Atomic Energy, Zijin Mining, Tianjin Rail Transit, and China Nonferrous Metal International Mining [1] Group 2 - Weisi Medical's shareholder plans to reduce its stake by up to 3%, totaling no more than 2.8731 million shares, due to personal funding needs [2] - Han Yi Co. intends to invest 102 million yuan to acquire a 39% stake in Shanghai Pidong Cultural Media, aiming to expand its IP derivative business [2] Group 3 - Zhongsheng High-Tech's controlling shareholder will change to Fuzhou Qianjing after signing a share transfer agreement, with stock resuming trading [3] - Tianli Lithium Energy plans to invest 30% in a joint venture for advanced energy research, contributing 30 million yuan [5] Group 4 - Zhenbang Intelligent plans to invest up to 11 million USD to establish a production base in Indonesia [8] - Shenhuo Co. aims to set up a 1.512 billion yuan industry fund focusing on strategic emerging industries [9] Group 5 - Shenhuo Co. intends to acquire a 14.69% stake in Shenhuo New Materials for 298 million yuan through public bidding [11] - Kema Technology plans to acquire a 73% stake in Suzhou Kaixin Semiconductor for 102 million yuan to enhance its capabilities in silicon carbide materials [13] Group 6 - China Power Construction's subsidiary won two major engineering projects with total contract values of approximately 57.52 billion yuan and 54.39 billion yuan [14] - Huaxin Environmental plans to reduce its stake by up to 1.58% due to personal funding needs [15] Group 7 - Yuandong Bio's shareholders plan to collectively reduce their stake by up to 1.91% for personal funding needs [17] - Xiangming Intelligent's controlling shareholder plans to reduce its stake by up to 3% due to personal funding needs [18] Group 8 - Sand Technology's actual controller's associates plan to reduce their stake by up to 2% for personal funding needs [19] - Beifang Changlong decided to terminate the acquisition of 51% of Henan Zhongzheng due to changes in market conditions [20] Group 9 - ST Huicheng plans to publicly transfer 30% of its subsidiary Peak Intelligent for a starting price of 5.1 million yuan [22] - Yunji Group's major shareholder plans to reduce its stake by up to 3% for personal funding needs [23] Group 10 - Shunbo Alloy plans to raise up to 600 million yuan through a private placement to enhance its main business [24] - Berry Gene's major shareholder will face judicial enforcement on 1% of its shares due to a pledge default [25] Group 11 - Guanglian Aviation's controlling shareholder is under investigation, but the company's operations remain normal [26]

Core Viewpoint - The announcement details the forced liquidation of shares held by major shareholder Mr. Gao Yang due to a default in a stock pledge repurchase agreement with Guoxin Securities, which has been ruled by the Chengyu Financial Court [1][2]. Group 1: Shareholder Information - Mr. Gao Yang holds 28,453,510 shares of Berry Genomics, accounting for 8.05% of the company's total share capital [1]. - The shares being executed amount to 3,535,214 shares, which are part of the stock pledged in a dispute with Guoxin Securities [1][2]. Group 2: Share Lock-up and Compliance - The shares subject to forced execution were acquired by Mr. Gao during a major asset restructuring transaction involving the purchase of 100% equity of Berry Genomics [2]. - Mr. Gao had previously committed to a lock-up period for these shares, which has now expired as the shares have been held for over 36 months without triggering any extension conditions [3]. Group 3: Legal and Regulatory Compliance - The forced execution of shares does not violate any previously disclosed holding intentions or commitments made by Mr. Gao [3]. - The company will ensure compliance with relevant laws and regulations during the execution process and will disclose any progress as required [3].

Summary of Key Points Core Viewpoint - The announcement details a significant change in shareholding for Chengdu Berry Genomics Co., Ltd. due to stock pledge defaults by a major shareholder, resulting in forced sales of shares through judicial auction [1]. Group 1: Shareholding Changes - The controlling shareholder, Gao Yang, had 157,230 shares sold, representing 0.04% of the total share capital, due to a stock pledge default [1]. - A total of 13,785,075 shares held by the associated party, Hou Ying, were auctioned, with 8,656,886 shares transferred on July 21, 2025, accounting for 2.45% of the total share capital [1]. - The total shares reduced by both Gao Yang and Hou Ying amounted to 8,814,116 shares, which is 2.49% of the total share capital [1]. Group 2: Shareholding Structure Post-Change - After the changes, the total shares held by the company decreased from 42,395,815 shares (11.99%) to 33,581,699 shares (9.50%) [2]. - The number of unrestricted shares held dropped from 18,404,273 shares (5.21%) to 9,590,157 shares (2.71%), while the restricted shares remained unchanged at 23,991,542 shares (6.79%) [2]. - The company confirmed that the judicial enforcement and auction did not adversely affect its operational or financial status, nor its governance structure [2].

证券代码：000710 证券简称：贝瑞基因 公告编号：2025-036 成都市贝瑞和康基因技术股份有限公司 关于持股5%以上股东所持部分股份被司法强制执行的提示性公告 股东高扬先生保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、高扬先生持有成都市贝瑞和康基因技术股份有限公司（以下简称"公司"或 "贝瑞基因"）股份 28,453,510 股（占公司总股本比例为 8.05%），为公司控股股 东。现因高扬先生在国信证券股份有限公司（以下简称"国信证券"）开展的股票质 押回购业务发生违约，成渝金融法院裁定强制变现被执行人高扬先生持有的 3,535,214 股"贝瑞基因"股票。 2、公司目前生产经营情况正常，该事项未对公司的生产经营及财务状况产生重 大不利影响，未对公司治理结构产生重大不利影响。 公司于近日收到股东高扬先生通知，其于近日收到成渝金融法院作出的(2024) 渝 87 执 4703 号之五《执行裁定书》，裁定强制变现被执行人高扬先生持有的 3,535,214 股"贝瑞基因"股票。现将有关情况 ...

证券代码：000710 证券简称：贝瑞基因 公告编号：2025-037 成都市贝瑞和康基因技术股份有限公司 关于控股股东及其一致行动人权益变动触及1%整数倍的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 控股股东高扬先生及一致行动人侯颖女士保证向本公司提供的信息内容真 实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 成都市贝瑞和康基因技术股份有限公司（以下简称"贝瑞基因"或"公司"） 于近日接到控股股东之一致行动人侯颖女士所持有股份发生变动的通知，现将本 次权益变动的具体情况公告如下： | 1．基本情况 | | | | | --- | --- | --- | --- | | 信息披露义务人 | 高扬 | | | | | | 侯颖（高扬之一致行动人） | | | 住所 | | 北京市昌平区科技园区生命园路 4 号院 5 号楼 | | | 权益变动时间 | 2025 | 年 5 月 23 | 日-2025 年 7 月 21 日 | | 权益变动过程 | 司在 | 2025 年 5 本 ...

Core Viewpoint - The major shareholder Gao Yang of Berry Genomics (000710.SZ) is facing judicial enforcement for the forced liquidation of 3,535,214 shares, representing 1% of the company's total equity, due to a breach of contract in a stock pledge repurchase agreement [1] Group 1 - The forced liquidation is a result of Gao Yang's default on a stock pledge repurchase business [1] - The court ruling was made by the Chengdu Financial Court [1] - The company states that this event will not have a significant adverse impact on its production, operations, or financial status [1] Group 2 - The forced sale will not significantly affect the company's governance structure [1]